Sh3bp1-flox Mouse

SH3BP1, also known as ARHGAP43, belongs to the RhoGAP family. It is an important regulator involved in multiple cellular processes. SH3BP1 specifically inactivates Rac1 and its target proteins like Wave2/WAVE2, and is associated with pathways related to cell motility, such as the Ral/exocyst and Rac signaling pathways. It plays a significant role in various biological processes including cell migration, epithelial junction formation, and is also relevant in disease-related contexts like cancer progression [1,3,5,6,7,8].

In melanoma, overexpression of SH3BP1 promoted cell proliferation, migration, and invasion through the Rac1/Wave2 signaling pathway [1]. In acute myeloid leukemia, higher SH3BP1 expression was associated with poor prognosis, and down-regulation of its expression inhibited cell proliferation [2]. In cervical cancer, SH3BP1 overexpression promoted invasion, migration, and chemoresistance via the Rac1/Wave2 pathway [3]. In chronic myeloid leukemia, interactions among Cobll1, PACSIN2, and SH3BP1 regulated drug resistance, with SH3BP1 promoting the SH3BP1/Rac1 pathway to suppress tyrosine kinase inhibitor-mediated apoptosis [4]. In hepatocellular carcinoma, SH3BP1 overexpression was associated with vascular invasion, and it promoted tumor invasion and microvessel formation through the Rac1-WAVE2 signaling, contributing to metastasis and recurrence [6].

In conclusion, SH3BP1 is a crucial regulator in multiple biological processes and disease conditions, especially in various cancers. Its role in activating or inactivating key signaling pathways like Rac1/Wave2 has been demonstrated through various in-vivo and functional studies. Understanding SH3BP1's functions may provide new therapeutic targets for treating related diseases, such as melanoma, acute myeloid leukemia, cervical cancer, chronic myeloid leukemia, and hepatocellular carcinoma.